TNNI3 and COVID-19: Of those, 6 (1%) presented with raised cardiac blood biomarkers (high hs-cTnI, n=4 and high NT-proBNP, n=2), but only 1/6 had abnormal CMR with both low LVEF and RVEF at 6 months and acute COVID-19 hospitalisation.